STOCK PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by over 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it co